Magnetic resonance imaging and spectroscopy of transgenic models of cancer

The complexity of cancer, where a single genetic alteration can have multiple functional effects, makes it a fascinating but humbling disease to study, and the necessity of investigating it in its entirety is more imperative than ever before. Advances in transgene technology have made it possible to create cancer cells, or mice with specific genetic alterations, and the application of an array of both functional and molecular non‐invasive MR methods to these transgenic cancer cells and mice to characterize their phenotypic traits is revolutionizing our understanding of cancer. With the establishment of multi‐modality molecular imaging centers within barrier or pathogen‐free facilities, multi‐parametric and multi‐modality imaging of transgenic mouse models of human cancer are becoming increasingly prevalent. In this review, we outline some of the methods currently available for generating transgenic mice and cancer cell lines. We also present examples of the application of MR methods to transgenic models that are providing novel insights into the molecular and functional characteristics of cancer and are leading to an era of ‘non‐invasive phenotyping’ of the effects of specific molecular alterations in cancer. Copyright © 2007 John Wiley & Sons, Ltd.

[1]  Arvind P Pathak,et al.  Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. , 2006, Cancer research.

[2]  G. Semenza,et al.  Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia‐inducible factor 1 , 2006, Experimental physiology.

[3]  S. Cherry.  Multimodality in vivo imaging systems: twice the power or double the trouble? , 2006, Annual review of biomedical engineering.

[4]  Paolo Valerio,et al.  Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. , 2006, Current medicinal chemistry.

[5]  H. Varmus,et al.  Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors. , 2006, Genes & development.

[6]  R. Mangues,et al.  Mouse models in oncogenesis and cancer therapy , 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[7]  K. Morris.  Therapeutic potential of siRNA-mediated transcriptional gene silencing. , 2006, BioTechniques.

[8]  Jinyuan Zhou,et al.  Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly‐L‐lysine and a starburst dendrimer , 2006, Magnetic resonance in medicine.

[9]  Yoshinori Kato,et al.  Noninvasive 1H/13C magnetic resonance spectroscopic imaging of the intratumoral distribution of temozolomide , 2006, Magnetic resonance in medicine.

[10]  V. Raman,et al.  RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. , 2005, Cancer research.

[11]  D. Largaespada,et al.  Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies. , 2005, Current gene therapy.

[12]  S. Abdulkadir,et al.  Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility. , 2005, Future oncology.

[13]  G. Daley,et al.  Therapeutic potential of embryonic stem cells. , 2005, Blood reviews.

[14]  Stefan Glaser,et al.  Current issues in mouse genome engineering , 2005, Nature Genetics.

[15]  Peter Carmeliet,et al.  VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.

[16]  G. Miller.  Mouse With Human Chromosome Should Boost Down Syndrome Research , 2005, Science.

[17]  Ying-ju Chen,et al.  Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5' internal ribosome entry site. , 2005, Biochemical and biophysical research communications.

[18]  Weili Lin,et al.  Magnetic resonance angiography visualization of abnormal tumor vasculature in genetically engineered mice. , 2005, Cancer research.

[19]  J. Rossant,et al.  Genetic regulation of stem cell origins in the mouse embryo , 2005, Clinical genetics.

[20]  M. Resnick,et al.  Constitutive activation of PI3K‐Akt and NF‐κB during prostate cancer progression in autochthonous transgenic mouse model , 2005, The Prostate.

[21]  A. Komar,et al.  Internal Ribosome Entry Sites in Cellular mRNAs: Mystery of Their Existence* , 2005, Journal of Biological Chemistry.

[22]  Brian Salmons,et al.  A 470 bp WAP-promoter fragment confers lactation independent, progesterone regulated mammary-specific gene expression in transgenic mice , 2005, Transgenic Research.

[23]  Michal Neeman,et al.  Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. , 2005, Neoplasia.

[24]  L. Naldini,et al.  Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.

[25]  J. Griffiths,et al.  The C-neu mammary carcinoma in Oncomice; characterization and monitoring response to treatment with herceptin by magnetic resonance methods , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[26]  J. Battey,et al.  Technical Assessment of the First 20 Years of Research Using Mouse Embryonic Stem Cell Lines , 2004, Stem cells.

[27]  Z. Bhujwalla,et al.  Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline. , 2004, Molecular imaging.

[28]  V. Prasad,et al.  Phenotypes of SERCA and PMCA knockout mice. , 2004, Biochemical and biophysical research communications.

[29]  G. Hannon,et al.  Unlocking the potential of the human genome with RNA interference , 2004, Nature.

[30]  V. Raman,et al.  Robust expression of transgenes in MCF-7 breast cancer cells is expression vector-dependent. , 2004, BioTechniques.

[31]  Z. Bhujwalla,et al.  Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer , 2004, Cancer Research.

[32]  A. Harris,et al.  Noninvasive Measurements of Capecitabine Metabolism in Bladder Tumors Overexpressing Thymidine Phosphorylase by Fluorine-19 Magnetic Resonance Spectroscopy , 2004, Clinical Cancer Research.

[33]  C. Kos.  Methods in Nutrition Science: Cre/loxP System for Generating Tissue-specific Knockout Mouse Models , 2004 .

[34]  C. Kos.  Special Article: Methods in Nutrition Science Cre/loxP System for Generating Tissue-specific Knockout Mouse Models , 2022 .

[35]  Martin Kupiec,et al.  New insights into the mechanism of homologous recombination in yeast. , 2004, Mutation research.

[36]  Jose J. Galvez,et al.  Validation: The New Challenge for Pathology , 2004, Toxicologic pathology.

[37]  R. Henkelman,et al.  High-resolution longitudinal screening with magnetic resonance imaging in a murine brain cancer model. , 2003, Neoplasia.

[38]  K. Wagner.  Models of breast cancer: quo vadis, animal modeling? , 2003, Breast Cancer Research.

[39]  Z. Bhujwalla,et al.  Choline phospholipid metabolism: A target in cancer cells? , 2003, Journal of cellular biochemistry.

[40]  Thomas J Meade,et al.  New magnetic resonance contrast agents as biochemical reporters , 2003, Current Opinion in Neurobiology.

[41]  E. Terreno,et al.  Supramolecular adducts between poly-L-arginine and [TmIIIdotp]: a route to sensitivity-enhanced magnetic resonance imaging-chemical exchange saturation transfer agents. , 2003, Angewandte Chemie.

[42]  M. O'hare,et al.  Models of breast cancer: is merging human and animal models the future? , 2003, Breast Cancer Research.

[43]  Mary E. Dickinson,et al.  Technicolour transgenics: imaging tools for functional genomics in the mouse , 2003, Nature Reviews Genetics.

[44]  P. Andreotti,et al.  Imaging of luciferase and GFP-transfected human tumours in nude mice. , 2003, Luminescence : the journal of biological and chemical luminescence.

[45]  Dmitri Artemov,et al.  Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.

[46]  Jens Kurreck,et al.  Antisense technologies. Improvement through novel chemical modifications. , 2003, European journal of biochemistry.

[47]  Dmitri Artemov,et al.  MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.

[48]  Hisataka Kobayashi,et al.  Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. , 2003, Cancer research.

[49]  M. Neeman,et al.  Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. , 2002, Cancer research.

[50]  L. del Peso,et al.  Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1. , 2002, International journal of oncology.

[51]  R. Rosell,et al.  Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. , 2002, Biochemical and biophysical research communications.

[52]  Jose M. Silva,et al.  Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy , 2002, Oncogene.

[53]  D. J. Jerry,et al.  Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer? , 2002, Breast Cancer Research.

[54]  R. Homer,et al.  Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling. , 2002, Seminars in cell & developmental biology.

[55]  Sheng-Kwei Song,et al.  Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. , 2002, Cancer research.

[56]  J. Lacal,et al.  Regulation of choline kinase activity by Ras proteins involves Ral–GDS and PI3K , 2002, Oncogene.

[57]  F. Bunz.  Human cell knockouts , 2002, Current opinion in oncology.

[58]  C. Deng,et al.  BRCA1-associated tumorigenesis: what have we learned from knockout mice? , 2001, Trends in genetics : TIG.

[59]  M. Lewandoski.  Conditional control of gene expression in the mouse , 2001, Nature Reviews Genetics.

[60]  M. Leach,et al.  Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells , 2001, British Journal of Cancer.

[61]  P. Humphrey,et al.  Impaired prostate tumorigenesis in Egr1-deficient mice , 2001, Nature Medicine.

[62]  A. Benabid,et al.  p53 Status and gene transfer experiments using CMV enhancer/promoter. , 2001, Biochemical and biophysical research communications.

[63]  A. Giaccia,et al.  Development of a hypoxia-responsive vector for tumor-specific gene therapy , 2000, Gene Therapy.

[64]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[65]  L. Hennighausen.  Mouse models for breast cancer , 1999, Breast Cancer Research.

[66]  Y. Morishita,et al.  Increased Choline Kinase Activity in 1,2‐Dimethylhydrazine‐induced Rat Colon Cancer , 1999, Japanese journal of cancer research : Gann.

[67]  F. Podo.  Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[68]  M. Vooijs,et al.  Developmental defects and tumor predisposition in Rb mutant mice , 1999, Oncogene.

[69]  R. Pankov,et al.  Ha‐ ras‐TRANSFORMATION ALTERS THE METABOLISM OF PHOSPHATIDYLETHANOLAMINE AND PHOSPHATIDYLCHOLINE IN NIH 3T3 FIBROBLASTS , 1999, Cell biology international.

[70]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Gillies,et al.  Nm23‐transfected MDA‐mB‐435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: A 31P nuclear magnetic resonance study in vivo and in vitro , 1999, Magnetic resonance in medicine.

[72]  P. Stricklett,et al.  The Cre/loxP system and gene targeting in the kidney. , 1999, American journal of physiology. Renal physiology.

[73]  Y. Morishita,et al.  Increased Choline Kinase Activity and Elevated Phosphocholine Levels in Human Colon Cancer† , 1999, Japanese journal of cancer research : Gann.

[74]  M. Ikawa,et al.  `Green mice' and their potential usage in biological research , 1998, FEBS letters.

[75]  G. Davies.  Structural studies on cellulases. , 1998, Biochemical Society transactions.

[76]  I. Su,et al.  Lac/Tet dual-inducible system functions in mammalian cell lines. , 1998, BioTechniques.

[77]  V. Sandig,et al.  Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFκB , 1998, Journal of Virology.

[78]  F. Podo,et al.  Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. , 1996, Anticancer research.

[79]  C. Kent,et al.  Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. , 1995, Archives of biochemistry and biophysics.

[80]  J. Vijg,et al.  LacZ transgenic mouse models: their application in genetic toxicology. , 1994, Mutation research.

[81]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[82]  C. Kent,et al.  Altered phosphatidylcholine metabolism in C3H10T1/2 cells transfected with the Harvey-ras oncogene. , 1990, The Journal of biological chemistry.

[83]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[84]  P Berg,et al.  Electroporation for the efficient transfection of mammalian cells with DNA. , 1987, Nucleic acids research.

[85]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[86]  J. Gray,et al.  A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.

[87]  K. Beyreuther,et al.  Gene transfer to human cells: transducing phage lambda plac gene expression in GMI-gangliosidosis fibroblasts. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[88]  L. F. Fajardo,et al.  Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. , 1972, Journal of the National Cancer Institute.

[89]  G. Semenza,et al.  Regulation of gene expression by HIF-1. , 2006, Novartis Foundation symposium.

[90]  F. Guillou,et al.  Mammalian genome targeting using site-specific recombinases. , 2006, Frontiers in bioscience : a journal and virtual library.

[91]  H. Kiyonari,et al.  Gene disruption/knock-in analysis of mONT3: vector construction by employing both in vivo and in vitro recombinations. , 2005, The International journal of developmental biology.

[92]  A. Trounson.  Derivation characteristics and perspectives for mammalian pluripotential stem cells. , 2005, Reproduction, fertility, and development.

[93]  Barjor Gimi,et al.  Molecular and functional imaging of cancer: advances in MRI and MRS. , 2004, Methods in enzymology.

[94]  A. Auerbach.  Production of functional transgenic mice by DNA pronuclear microinjection. , 2004, Acta biochimica Polonica.

[95]  M. Fussenegger,et al.  Inducible gene expression in mammalian cells and mice. , 2004, Methods in molecular biology.

[96]  S. Heck,et al.  Genetically engineered mouse models for drug discovery: new chemical genetic approaches. , 2004, Current drug discovery technologies.

[97]  F. Recillas-Targa.  Gene transfer and expression in mammalian cell lines and transgenic animals. , 2004, Methods in molecular biology.

[98]  A. Sands,et al.  Knockouts model the 100 best-selling drugs—will they model the next 100? , 2003, Nature Reviews Drug Discovery.

[99]  D Artemov,et al.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.

[100]  K. Ghoshal,et al.  Regulation of metallothionein gene expression. , 2001, Progress in nucleic acid research and molecular biology.

[101]  Z. Bhujwalla,et al.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.

[102]  A. Chan,et al.  Transgenic animals: current and alternative strategies. , 1999, Cloning.

[103]  Clark Aj.  Gene expression in the mammary glands of transgenic animals. , 1998 .

[104]  J. Warren,et al.  Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats. , 1998, Biochemical Society symposium.

[105]  A. Clark.  Gene expression in the mammary glands of transgenic animals. , 1998, Biochemical Society symposium.